Given TGF-β’s involvement in key processes of liver fibrosis, including HSCs activation, ECM production, immunoregulation, and fibrosis reversal, TGF-β and its associated signaling pathways have emerged as critical therapeutic targets. This evidence concerns the gene TGFB1 and Hepatic fibrosis.